Zobrazeno 1 - 3
of 3
pro vyhledávání: ''
Autor:
Mario Lukacevic, Tobias Borchert, James T. Thackeray, Annika Hess, Frank M. Bengel, Tobias L. Ross
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging
Purpose Myocardial infarction (MI) triggers a local inflammatory response which orchestrates cardiac repair and contributes to concurrent neuroinflammation. Angiotensin-converting enzyme (ACE) inhibitor therapy not only attenuates cardiac remodeling
Autor:
Jason T. Lee, András Füredi, Oliver Langer, R. Michael van Dam, Divya Maheshwari, Theresa Falls, Pavitra Kannan, Gergely Szakács, Severin Mairinger, Sabina Dizdarevic, Jeffrey Collins, Thomas Wanek
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging
Purpose Multidrug resistance (MDR) impedes cancer treatment. Two efflux transporters from the ATP-binding cassette (ABC) family, ABCB1 and ABCG2, may contribute to MDR by restricting the entry of therapeutic drugs into tumor cells. Although a higher
Autor:
Pierre Bourgeois, Guus A.M.S. van Dongen, Thomas Guiot, Melanie Vaes, Hendrik Everaert, Patrick Flamen, Danielle J. Vugts, Nathalie Meuleman, Bruno Vanderlinden, Kristoff Muylle, Dominique Bron, Ghanem Elias Ghanem
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging
Muylle, K, Flamen, P, Vugts, D, Guiot, T, Ghanem, G, Meuleman, N, Bourgeois, P, Vanderlinden, B, van Dongen, G A M S, Everaert, H, Vaes, M & Bron, D 2015, ' Tumour targeting and radiation dose of radioimmunotherapy with Y-90-rituximab in CD20+B-cell lymphoma as predicted by Zr-89-rituximab immuno-PET: impact of preloading with unlabelled rituximab ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 42, no. 8, pp. 1304-1314 . https://doi.org/10.1007/s00259-015-3025-6
European journal of nuclear medicine and molecular imaging, 42 (8
European Journal of Nuclear Medicine and Molecular Imaging, 42(8), 1304-1314. Springer Verlag
Muylle, K, Flamen, P, Vugts, D, Guiot, T, Ghanem, G, Meuleman, N, Bourgeois, P, Vanderlinden, B, van Dongen, G A M S, Everaert, H, Vaes, M & Bron, D 2015, ' Tumour targeting and radiation dose of radioimmunotherapy with Y-90-rituximab in CD20+B-cell lymphoma as predicted by Zr-89-rituximab immuno-PET: impact of preloading with unlabelled rituximab ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 42, no. 8, pp. 1304-1314 . https://doi.org/10.1007/s00259-015-3025-6
European journal of nuclear medicine and molecular imaging, 42 (8
European Journal of Nuclear Medicine and Molecular Imaging, 42(8), 1304-1314. Springer Verlag
Purpose: To compare using immuno-PET/CT the distribution of 89Zr-labelled rituximab without and with a preload of unlabelled rituximab to assess the impact of preloading with unlabelled rituximab on tumour targeting and radiation dose of subsequent r